SRC inhibitors (Lead Discovery/University of Siena/University of Pisa/University of L'Aquila/University of Genova/Temple University)

N/A

Report date: 2025/01/26 18:58:09
NME

Base Information

Drug NameSRC inhibitors (Lead Discovery/University of Siena/University of Pisa/University of L'Aquila/University of Genova/Temple University)
Drug Alias NameSI-306
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionTyrosine-protein kinase SRC inhibitors
TargetsTyrosine-protein kinase SRC
Therapy Area/IndicationsGlioblastoma
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryItaly
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesLead Discovery Siena Srl
China Registration ClassN/A

Develop Information

Active CompaniesLead Discovery Siena SrlUniversita Degli Studi Di L'AquilaUniversity Of Pisa +[6] 
Inactive CompaniesN/A
Active IndicationsGlioblastoma
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A